Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty RegistryShow others and affiliations
2024 (English)In: Heart, ISSN 1355-6037, E-ISSN 1468-201X, Vol. 110, no 22, p. 1307-1315Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Percutaneous coronary intervention (PCI) is frequently used for patients with chronic coronary syndrome (CCS). However, the role of PCI beyond symptom relief in CCS remains controversial. The objective of this study was to determine whether PCI is associated with better outcomes, compared with medical therapy (MT) alone.
METHODS: We conducted a retrospective cohort study. Using the Swedish Coronary Angiography and Angioplasty Registry, we included all patients with CCS undergoing coronary angiography in Sweden between 2010 and 2020. Two groups were formed based on treatment strategy: PCI+MT versus MT alone. One-to-one propensity score (PS) matching was used to address confounding. Outcome was assessed using matched win ratio analysis, a statistical method that ranks the components of the composite by clinical importance. The primary outcome was net adverse clinical event (NACE) within 5 years. In the win ratio analysis, the components of NACE were ranked as follows: (1) all-cause mortality, (2) myocardial infarction (MI), (3) bleeding and (4) urgent revascularisation. Secondary outcomes were the individual components of NACE, major adverse cardiovascular events (MACE) and cardiovascular mortality.
RESULTS: After PS matching, two groups of 7220 patients each were formed. The hierarchical outcome analysis of NACE and MACE showed that PCI was associated with improved outcome (matched win ratio: 1.28 (95% CI 1.20 to 1.36, p<0.001) and matched win ratio: 1.38 (95% CI 1.29 to 1.48, p<0.001), respectively). The use of PCI was associated with higher win ratio of MI (matched win ratio: 1.15, 95% CI 1.04 to 1.28, p=0.008), urgent revascularisation (matched win ratio: 1.85, 95% CI 1.69 to 2.03, p<0.001) and cardiovascular mortality (matched win ratio: 1.15, 95% CI 1.00 to 1.34, p=0.044). No difference in win ratio was observed for all-cause mortality or bleeding.
CONCLUSIONS: In this study, which sought to evaluate the outcomes of patients with CCS using a hierarchical approach, patients selected for revascularisation with PCI experienced better outcome compared with MT alone.
Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2024. Vol. 110, no 22, p. 1307-1315
Keywords [en]
Angina Pectoris, Atherosclerosis, Cardiovascular Diseases, Percutaneous Coronary Intervention, Pharmacology, Clinical
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:oru:diva-115716DOI: 10.1136/heartjnl-2024-324307ISI: 001303040600001PubMedID: 39214681Scopus ID: 2-s2.0-85204036589OAI: oai:DiVA.org:oru-115716DiVA, id: diva2:1894076
Funder
Swedish Heart Lung FoundationKnut and Alice Wallenberg FoundationRegion SkåneThe Crafoord FoundationSwedish Society of Medicine
Note
Funding: This work was supported by the Swedish Heart and Lung Foundation, Knut and Alice Wallenberg Foundation, ALF, Skane University Hospital Funds, Märta Winkler Foundation, Thorsten Westerströms Foundation, Sven-Eric Lundgren Foundation for Medical Research, the Crafoord Foundation and the Swedish Society of Medicine.
2024-09-022024-09-022025-02-10Bibliographically approved